We are the architects of targeted RNA.
Sixfold Bioscience has raised €9.2M across 1 funding round from 5 investors, most recently a Seed round in Dec 2021. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-06 | Seed | €9.2M |
| Angel Investors,Cantos Ventures,Lombard Street Ventures,Pi Campus,Y Combinator |
| View deal → |
